"There is no question that better management of diabetes results in better outcomes for the patient," Aspy said. "By offering a lancing device that results in least painful testing, we are helping to remove one of the barriers to adequate testing for improved diabetes management."
The comparative pain study was conducted by Dr. Richard Koubek, of Koubek and Associates, on behalf of Roche.
About Roche Diabetes Care
Roche Diabetes Care is a pioneer in the development of blood glucose monitoring systems and a global leader for diabetes management systems and services. For more than 30 years, Roche has been committed to helping people with diabetes live lives that are as normal and active as possible and has been helping healthcare professionals manage their patients' condition in an optimal way. Today, the ACCU-CHEK portfolio offers people with diabetes and healthcare professionals innovative products, services and comprehensive solutions for convenient, efficient and effective diabetes management-from blood glucose monitoring through information management to insulin delivery. The ACCU-CHEK brand encompasses blood glucose meters, infusion pumps, lancing and data management systems.
For more information, please visit accu-chek.com.
Headquartered in Basel, Switzerland, Roche is one of the world's leading
research-focused healthcare groups in the fields of pharmaceuticals and
diagnostics. As the world's largest biotech company and an innov
|SOURCE Roche Diabetes Care|
Copyright©2008 PR Newswire.
All rights reserved